, she designed and led the Office of Clinical Trials, key to advancing translational research. She launched marketing and outreach programs to convey Mount Sinai’s research capabilities. These efforts attracted ongoing contracts from Novartis, Smith Kline Beecham, Amgen and Pfizer and other pharmaceutical and bi

ences. Strengthened overall regulatory compliance and fiscal compliance with third party payors. e Launched marketing and outreach program to convey Mount Sinai’s research capabilities. e Attracted ongoing contracts and right of first refusal in phase III clinical trials (with appropriate patient populations)